Opioid addiction affects physical health, emotional well-being, relationships, and daily life. Questions about medication often come up when someone is considering opioid addiction treatment. Clinicians use the term opioid use disorder, or OUD, to describe a pattern of opioid use that causes significant health or daily-life problems. OUD is treatable. For people living with opioid use disorder, medication are prescribed in treatment based on a patient’s health, symptoms, goals, and stage of recovery.
The FDA has approved three medications for opioid use disorder: buprenorphine, methadone, and naltrexone. Each medication works differently. Some help reduce withdrawal symptoms and cravings. Others block the effects of opioids. A clinician can review the benefits, risks, and timing of each option. They can also determine which medication may fit the patient’s needs.
Providers often refer to these medications as medications for opioid use disorder, or MOUD. They may also use the term medication-assisted treatment, or MAT, when medication is combined with counseling and other clinical services. The sections below explain these terms and how each medication works. They also cover the role of therapy and ongoing support. Milton Recovery Centers provides individualized treatment for addiction and co-occurring mental health conditions in a setting focused on dignity, comfort, and respect.
What Is Opioid Use Disorder?
Opioid use disorder, or OUD, is a medical condition in which opioid use becomes difficult to control and continues despite harm to a person’s health or daily life. It can involve prescription opioids, heroin, fentanyl, or other opioids. OUD can range from mild to severe, and its effects may extend into a person’s work, relationships, finances, physical health, and emotional well-being.
Physical dependence alone does not necessarily mean that someone has OUD. A patient taking opioids as prescribed may develop tolerance or experience withdrawal if the medication is stopped. Opioid use disorder involves a broader pattern of symptoms and should be assessed by a qualified healthcare professional.
Common Signs and Effects of Opioid Use Disorder
The signs of OUD are not always immediately apparent. According to the CDC’s diagnostic guidance, they may include:
- Taking opioids in larger amounts or for longer than intended
- Wanting to reduce opioid use but having difficulty doing so
- Experiencing strong cravings
- Spending significant time obtaining, using, or recovering from opioids
- Falling behind on responsibilities at work, school, or home
- Withdrawing from social, occupational, or recreational activities
- Continuing to use opioids despite physical, emotional, or relationship problems
- Using opioids in situations that create a risk of injury
- Developing tolerance or experiencing withdrawal outside of appropriate medical supervision
Opioid Use Disorder affects sleep, mood, concentration, judgment, and physical health. OUD can also increase the risk of accidental injury and overdose. Injecting opioids or sharing paraphernalia raises the risk of infections such as HIV and hepatitis C. Combining opioids with alcohol, benzodiazepines, or other substances that slow breathing can lead to more serious effects. A clinician considers the full pattern of symptoms rather than relying on any single sign to make a diagnosis.
Why Clinicians Consider OUD a Health Condition Requiring Addiction Treatment
Clinicians consider opioid use disorder (OUD) a health condition because repeated opioid use can produce lasting changes in the brain systems involved in reward, stress, decision-making, and impulse control. These changes can make it difficult for a person to reduce or stop opioid use even when they recognize the harm it is causing. OUD is not simply a matter of willpower or poor choices. It is a treatable medical condition that can affect physical health, mental health, relationships, and daily functioning. Professional addiction treatment may include medications for opioid use disorder, behavioral therapies, medical care, counseling, and ongoing recovery support. By treating OUD as a health condition, clinicians can address both the biological and behavioral aspects of addiction while helping patients reduce overdose risk, stabilize their health, and build a sustainable path toward recovery.
What Medications Are FDA-Approved for Treating OUD?
Medication can play an important role in treating opioid use disorder (OUD), particularly when withdrawal symptoms, cravings, and repeated opioid use make it difficult for someone to stabilize without medical support. The U.S. Food and Drug Administration (FDA) recognizes three medications for the treatment of OUD: methadone, buprenorphine, and naltrexone. Each works differently, and there is no single medication that is appropriate for every patient.
Healthcare providers frequently label these medications as medications for opioid use disorder (MOUD). They may be incorporated into a larger addiction treatment plan that includes medical care, behavioral therapy, psychiatric services, peer support, and recovery planning.
Methadone for Opioid Addiction Treatment
Methadone has the longest history of the three medications in the treatment of opioid addiction. Researchers began studying methadone maintenance for opioid addiction in the 1960s, and the FDA approved methadone for treating opioid addiction in 1972.
Methadone is a long-acting full opioid agonist, meaning it activates the same opioid receptors involved in the effects of drugs such as heroin and prescription opioids. When appropriately prescribed and monitored, however, methadone can prevent or reduce withdrawal symptoms, decrease cravings, and help stabilize patients without producing the repeated cycles of intoxication and withdrawal associated with uncontrolled opioid use.
Research has associated methadone treatment with reductions in illicit opioid use and a lower risk of overdose death.
Regulators regulate methadone treatment for OUD more tightly than other FDA-approved medications. Learn more about methadone and other approved OUD medications from the FDA’s Medications for Opioid Use Disorder resource.
Buprenorphine for Opioid Addiction Treatment
Buprenorphine changed the way many patients could access medication treatment for OUD. The FDA approved buprenorphine products Subutex and Suboxone in October 2002 for the treatment of opioid dependence.
Unlike methadone, buprenorphine is a partial opioid agonist. It activates opioid receptors, but its effects are more limited than those of full opioid agonists. This allows buprenorphine to reduce withdrawal symptoms and cravings while providing a different safety profile than full agonists.
Buprenorphine is available in several formulations, including sublingual tablets and films as well as extended-release injections. Current FDA-approved products include medications such as Suboxone, Sublocade, Brixadi, and Zubsolv, along with generic buprenorphine and buprenorphine/naloxone products.
One of the most important developments in buprenorphine’s history involved access to treatment. The Drug Addiction Treatment Act of 2000 helped make office-based opioid addiction treatment possible, and buprenorphine became the first medication approved for this model of care.
For years, clinicians generally needed a special federal waiver, commonly known as an X-waiver, to prescribe buprenorphine for OUD. In 2023, regulators eliminated the federal waiver requirement, expanding appropriately registered practitioners’ ability to provide buprenorphine treatment.
The FDA has continued expanding buprenorphine treatment options. In 2023, for example, the agency approved Brixadi, an extended-release injectable buprenorphine product available in weekly and monthly formulations.
Naltrexone for Opioid Addiction Treatment
Naltrexone works differently from both methadone and buprenorphine. Rather than activating opioid receptors, naltrexone is an opioid antagonist, meaning it occupies and blocks opioid receptors. As a result, opioids do not produce their usual euphoric and sedating effects while the medication is active.
Naltrexone also has a long history in addiction medicine. The FDA approved the oral naltrexone product Trexan in 1984 for use related to maintaining an opioid-free state in people who had undergone detoxification.
Another major development occurred in 2010, when the FDA approved extended-release injectable naltrexone, marketed as Vivitrol, for the prevention of relapse to opioid dependence following opioid detoxification.
Today, the extended-release injectable formulation of naltrexone is the FDA-approved naltrexone option for treating OUD. It is generally administered approximately once a month.
An important difference is that a patient must be opioid-free before beginning naltrexone. Starting it while opioids are still present in the body can cause precipitated withdrawal. Research recommends waiting at least seven days after short-acting opioids and 10 to 14 days after long-acting opioids, with timing determined clinically for each patient.
How Do Clinicians Choose an OUD Medication?
Choosing between methadone, buprenorphine, and naltrexone requires an individualized clinical assessment. A treatment provider may consider the type and pattern of opioid use, level of physical dependence, previous treatment experiences, withdrawal risk, other medical or psychiatric conditions, current medications, access to treatment, and the patient’s preferences and recovery goals.
The medications are not interchangeable, and treatment does not necessarily have a predetermined end date. For some patients, medication may be appropriate for months or years. Others may benefit from longer-term treatment. Healthcare providers can use medications for OUD safely when appropriate, and patients should work with their provider before changes.
Clinicians should not see using medication to treat OUD as merely substituting one substance for another. Medications such as methadone, buprenorphine, and extended-release naltrexone reduce the symptoms and risks of opioid use disorder. Studies show that methadone, buprenorphine, and extended-release naltrexone reduce illicit opioid use, and methadone and buprenorphine reduce the risk of overdose death.
What Is Medication-Assisted Treatment (MAT)?
Medication-assisted treatment, or MAT, is a familiar term for treating substance use disorders with medication, counseling, and behavioral therapies. In opioid addiction treatment, MAT may involve buprenorphine, methadone, or naltrexone along with other services selected for the patient.
Treatment does not look the same for everyone. Some patients may need intensive therapy and medical support, while others may benefit from medication management and outpatient counseling. The purpose is to address both the physical effects of opioid use and the emotional, behavioral, and social factors that can influence recovery.
What Is the Difference Between MOUD and MAT?
MAT and MOUD are often used to describe similar approaches, but the terms emphasize different areas. MAT highlights medication as one part of a treatment plan that also includes behavioral services. MOUD specifically refers to medications used to treat opioid use disorder.
Many healthcare organizations now use MOUD because it makes clear that medication is a recognized treatment for OUD, not simply an aid added to counseling. It also distinguishes opioid use disorder treatment from medication-based care for other substance use disorders. Readers may still see MAT used by treatment programs, insurers, government agencies, and healthcare providers, so both terms remain relevant.
Regardless of the term used, treatment should be based on a clinical assessment and the patient’s individual needs. Medication, therapy, psychiatric care, peer support, and other services can be coordinated without assuming that every person needs the same combination.
Does Taking Medication Replace One Addiction With Another?
No. Taking an FDA-approved medication as prescribed for opioid use disorder is not the same as continuing uncontrolled opioid use. Addiction involves patterns such as impaired control, cravings, and continued use despite serious harm. Properly managed medication is used to reduce those patterns and help the patient regain stability.
Buprenorphine and methadone do act on opioid receptors, and the body can become physically dependent on them. Physical dependence means withdrawal may occur if a medication is stopped suddenly. It is not the same as addiction. When these medications are taken at a clinically appropriate amount, they can control withdrawal and cravings without producing the repeated highs and crashes associated with heroin, fentanyl, or misused prescription opioids. Naltrexone is not an opioid and does not cause opioid dependence.
These medications still require appropriate prescribing, monitoring, and storage. Buprenorphine and methadone can be misused, and combining them with alcohol or other sedating substances can be dangerous. These risks require careful medical oversight and should be weighed against the serious risks associated with untreated OUD.
How Do Clinicians Determine Which OUD Medication May Be Appropriate?
Choosing a medication for opioid use disorder begins with a clinical assessment. A provider may ask about the opioids a patient has been using, when they were last used, previous overdoses, current withdrawal symptoms, and past attempts at treatment. Medical conditions,
mental health symptoms, other prescriptions, pregnancy, and the use of alcohol or sedating medications can also affect the decision.
Practical needs matter. Methadone for OUD is generally provided through a certified opioid treatment program, while buprenorphine can be prescribed in a wider range of healthcare settings.
Naltrexone requires an opioid-free period before treatment begins. Transportation, appointment schedules, medication access, and the patient’s comfort with daily medication or extended-release injections may influence which option can be used consistently.
A provider should consider the patient’s preferences and previous experiences with medication. The initial medication choice can be reevaluated as treatment progresses. Effectiveness, side effects, cravings, continued opioid use, and changes in health can be reviewed over time.
Why Medication Is Often Combined With Therapy and Recovery Support
Medication can address cravings, withdrawal, and other physical aspects of opioid use disorder. Therapy offers a place to work on concerns that medication alone may not resolve, such as trauma, stress, relationships, emotional regulation, or patterns connected to substance use.
Depending on the patient, treatment may include individual counseling, group therapy, family support, relapse-prevention planning, or help rebuilding daily routines. Peer services and recovery communities can provide connection with people who understand the challenges of making long-term changes. Support with housing, transportation, employment, or legal concerns may also make it easier to remain engaged in care.
These services can strengthen a treatment plan, but access to medication should not depend on a person completing a particular kind of counseling. Some patients benefit from several forms of support, while others need a more focused approach. Care should be adjusted around the person rather than forcing every patient through the same program.
Can Opioid Use Disorder and Mental Health Conditions Be Treated Together?
Yes. Opioid use disorder can be treated at the same time as depression, anxiety, post-traumatic stress disorder, bipolar disorder, schizophrenia, and other mental health conditions. Treating both is often important because symptoms can interact. A person may use opioids to cope with emotional distress, while opioid use, withdrawal, and disrupted sleep can make mental health symptoms harder to manage.
An integrated treatment plan for dual diagnosis coordinates medication management, psychiatric care, therapy, and addiction services. Providers also need to consider possible medication interactions and whether certain symptoms are related to a mental health condition, substance use, withdrawal, or a combination of factors. That picture may become clearer as the patient stabilizes.
Integrated care can reduce the burden of navigating disconnected systems and help the clinical team better understand the patient’s needs. Integrated treatment is recommended for people living with both substance use and mental health disorders. The goal is to support the whole person without requiring one condition to be resolved before care for the other can begin.
Finding Specialized Opioid Use Disorder Treatment Near Me
Finding the right opioid use disorder treatment involves more than locating a program that offers medication. Patients and families should ask how the clinical team evaluates OUD and how they monitor progress. They should ask which medications the team can provide and what mental health support they offer.
A specialized program should consider the person’s opioid use, overdose risk, physical health, emotional well-being, living situation, and previous treatment experiences. The level of care matters too. Some patients may need a highly structured program, while others can receive appropriate support through partial hospitalization, intensive outpatient treatment, or outpatient services.
Continuity is especially important with OUD medication. Ask how your prescriptions will be managed and whether the team can coordinate with outside prescribers when needed. Insurance coverage, transportation, family involvement, and plans for ongoing care may also affect whether treatment is sustainable.
Take the Next Step for Opioid Addiction Treatment at Milton Recovery Centers
Milton Recovery Centers provide addiction and co-occurring mental health treatment in North Palm Beach, Florida for individuals seeking support in South Florida, as well as in Steubenville for those seeking care in Ohio. Care is built around clinical assessment, medication management, therapy, and services that reflect each patient’s needs. Treatment takes place in an environment designed to feel welcoming, respectful, and free from shame.
When clinically appropriate, the care team includes medication-assisted treatment at Milton Recovery. The care team reviews health history, symptoms, treatment goals, and other relevant factors before discussing available options to determine what medication would be appropriate.
If opioid use is affecting your health or daily life, you do not have to determine the right treatment on your own. Contact our team to speak with the admissions team, ask questions about available OUD services, and learn what the next step may look like.
